KDM3A promotes inhibitory cytokines secretion by participating in TLR4 regulation of Foxp3 transcription in lung adenocarcinoma cells

Li,Yinan; Yang,Wei; Wu,Bin; Liu,Yaqing; Li,Dongbei; Guo,Yantong; Fu,Haiying; Li,Yi

doi:10.3892/ol.2017.5949

KDM3A promotes inhibitory cytokines secretion by participating in TLR4 regulation of Foxp3 transcription in lung adenocarcinoma cells

Authors:
- Yinan Li
- Wei Yang
- Bin Wu
- Yaqing Liu
- Dongbei Li
- Yantong Guo
- Haiying Fu
- Yi Li
View Affiliations

Affiliations: Department of Immunology, College of Basic Medical Science, Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: March 29, 2017 https://doi.org/10.3892/ol.2017.5949
Pages: 3529-3537
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Toll-like receptor 4 (TLR4) is a pattern recognition receptors, a member of the Toll-like receptor family and it serves a role in innate and acquired immunity. It has previously been reported that TLR4 was overexpressed in a variety of tumor tissues and cells, including colorectal cancer, gastric cancer and ovarian cancer. In the tumor microenvironment, the TLR4 signaling pathway may be activated in order to upregulate forkhead box P3 (Foxp3) expression in regulatory T cells (Tregs), and thus enhance the immunosuppressive function of Tregs. Also, inflammatory cytokine release would be increased, which promotes tumor immune system evasion. Additionally, it has previously been reported that TLR4 activation may induce histone methylation changes at multiple sites. However, the effects of the alterations to histone methylation in the process of TLR4‑associated tumor immune system evasion are not currently known. Histone methylation serves a critical role in regulating gene expression. Abnormal histone methylation is closely associated with tumor development and progression. In order to investigate the epigenetic mechanisms underlying Foxp3 regulation by TLR4, the human lung adenocarcinoma cell line A549 was used. In the present study, it was revealed that the expression level of H3K9me1/2 histone lysine demethylase 3A (KDM3A) was significantly increased following TLR 4 activation in the lung adenocarcinoma A549 cell line, whereas silencing of KDM3A expression led to significantly reduced Foxp3 expression under TLR4 regulation. This result suggests that KDM3A participates in TLR4 regulation of Foxp3 transcription. Additional analysis revealed that during nuclear transport of Foxp3, KDM3A may directly bind to the Foxp3 promoter and activate its transcription. This results in increased secretion of Foxp3-downstream inhibitory cytokines, including transforming growth factor‑β1 (TGF‑β1), interleukin 35 (IL‑35) and heme oxygenase 1 (HO‑1), which have immunosuppressive effects and ultimately facilitate the immune escape of lung cancer cells. From the results, the present study concluded that TLR4 activation promoted the expression of H3K9me1/2 demethylase KDM3A. KDM3A bound directly to the Foxp3 promoter and promoted Foxp3 transcription, thereby inducing the secretion of Foxp3‑associated downstream inhibitory cytokines (TGF‑β1, IL‑35, and HO‑1), ultimately facilitating the immune system evasion of lung adenocarcinoma.

View Figures

View References

1	Alam H, Gu B and Lee MG: Histone methylation modifiers in cellular signaling pathways. Cell Mol Life Sci. 72:4577–4592. 2015. View Article : Google Scholar : PubMed/NCBI
2	Herzog M, Josseaux E, Dedeurwaerder S, Calonne E, Volkmar M and Fuks F: The histone demethylase Kdm3a is essential to progression through differentiation. Nucleic Acids Research. 40:7219–7232. 2012. View Article : Google Scholar : PubMed/NCBI
3	Rea S, Eisenhaber F, OCarroll D, Strahl BD, Sun ZW, Schmid M, Opravil S, Mechtler K, Ponting CP, Allis CD and Jenuwein T: Regulation of chormatin structure by site-specific histone H3 methyltransferase. Nature. 406:593–599. 2000. View Article : Google Scholar : PubMed/NCBI
4	Gol IMG and Bestor TH: Histone modification and replacement in chromatin activation. Genes Dev. 16:1739–1742. 2002. View Article : Google Scholar : PubMed/NCBI
5	Suikki HE, Kujala PM, Tammela TL, van Weerden WM, Vessella RL and Visakorpi T: Genetic alterations and changes in expression of histone demethylases in prostate cancer. Prostate. 70:889–898. 2010.PubMed/NCBI
6	Yang J, Ledaki I, Turley H, Gatter KC, Montero JC, Li JL and Harris AL: Role of hypoxia-inducible factors in epigenetic regulation via histone demethylases. Ann N Y Acad Sci. 1177:185–197. 2009. View Article : Google Scholar : PubMed/NCBI
7	Wang GG, Allis CD and Chi P: Chromatin remodeling and cancer, part I: Covalent histone modification. Trends Mol Med. 13:363–372. 2007. View Article : Google Scholar : PubMed/NCBI
8	Xiang Y, Zhu Z, Han G, Lin H, Xu L and Chen CD: JMJD is a histone H3K27 demethylase. Cell Res. 17:850–857. 2007. View Article : Google Scholar : PubMed/NCBI
9	Nichol N, Dupéré-Richer D, Ezponda T, Licht JD and Miller WH Jr: H3K27 methylation: A focal point of epigenetic deregulation in cancer. Adv Cancer Res. 131:59–95. 2016. View Article : Google Scholar : PubMed/NCBI
10	Yamane K, Toumazou C, Tsukada Y, Erdjument-Bromage H, Tempst P, Wong J and Zhang Y: JHDM2A, a Jmjc-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell. 125:483–495. 2006. View Article : Google Scholar : PubMed/NCBI
11	Liu Y, Zhang Q, Ding Y, Li X, Zhao D, Zhao K, Guo Z and Cao X: Histone lysine methyltransferase Ezh1 promotes TLR-triggered inflammatory cytokines production by suppressing tollip. J Immunol. 194:2838–2846. 2015. View Article : Google Scholar : PubMed/NCBI
12	Takeda K and Akira S: Toll-like receptors in innate immunity. Int Immunol. 17:1–141. 2005. View Article : Google Scholar : PubMed/NCBI
13	Li TT, Ogiono S and Qian ZR: Toll-like receptor signaling in colorectal cancer: Carcinogenesis to cancer therapy. Word J Gastroenterol. 20:17699–17708. 2014.
14	Wang L, Zhao Y, Qian J, Sun L, Lu Y, Li H, Li Y, Yang J, Cai Z and Yi Q: Toll-like receptor-4 signaling in mantle cell lymphoma: Effects on tumor growth and immune evasion. Cancer. 119:782–791. 2013. View Article : Google Scholar : PubMed/NCBI
15	Schmausser B, Andrulis M, Endrich S, Mȕller-Hermelink HK and Eck M: Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: An implication for interaction with Helicobacter pylori. Int J Med Microbiol. 295:179–185. 2005. View Article : Google Scholar : PubMed/NCBI
16	Zhou M, McFarland-Mancini MM, Funk HM, Husseinzadeh N, Mounajjed T and Drew AF: Toll-like receptor expression in normal ovary and ovarian tumors. Cancer Immunol Immunother. 58:1375–2385. 2009. View Article : Google Scholar : PubMed/NCBI
17	Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, Bando Y, Kudo E, Shimada M and Sano T: High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer. 102:908–915. 2010. View Article : Google Scholar : PubMed/NCBI
18	Milkova L, Voelcker V, Forstreuter I, Sack U, Andereqq U, Simon JC and Maier-Simon C: The NF-kappaB signaling pathway is involved in the LPS/IL-2-induced upregulation of Foxp3 expression in human CD4+CD25high regulatory T cells. Exp Dermatol. 19:29–37. 2010. View Article : Google Scholar : PubMed/NCBI
19	Li B, Samanta A, Song X, Furuuchi K, Iacono KT, Kennedy S, Katsumata M, Saouaf SJ and Greene MI: FOXP3 ensembles in T-cell regulation. Immunol Rev. 212:99–131. 2006. View Article : Google Scholar : PubMed/NCBI
20	Schmitt EG and Williams CB: Generation and function of induced regulatory T cells. Front Immunol. 4:1522013. View Article : Google Scholar : PubMed/NCBI
21	Karanikas V, Speletas M, Zamanakou M, Kalala F, Loules G, Kerenidi T, Barda AK, Gourgoulianis KI and Germenis AE: Foxp3 expression in human cancer cells. J Transl Med. 6:192008. View Article : Google Scholar : PubMed/NCBI
22	He W, Liu Q, Wang L, Chen W, Li N and Cao X: TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol. 44:2850–2859. 2007. View Article : Google Scholar : PubMed/NCBI
23	Hinz S, Pagerols-Raluy L, Oberg HH, Ammerpohl O, Grȕssel S, Sipos B, Grȕtzmann R, Pilarsky C, Unqefroren H, Saeqer HD, et al: Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res. 67:8344–8350. 2007. View Article : Google Scholar : PubMed/NCBI
24	Merlo A, Casalini P, Carcangiu ML, Malventano C, Triulzi T, Mènard S, Tagliabue E and Balsari A: FOXP3 expression and overall survival in breast cancer. J Clin Oncol. 27:1746–1752. 2009. View Article : Google Scholar : PubMed/NCBI
25	Wang L, Liu R, Li W, Chen C, Katoh H, Chen GY, McNally B, Lin L, Zhou P, Zuo T, et al: Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell. 16:336–346. 2009. View Article : Google Scholar : PubMed/NCBI
26	Triulzi T, Tagliabue E, Balsari A and Casalini P: FOXP3 expression in tumor cells and implications for cancer progression. J Cell Physiol. 228:30–35. 2013. View Article : Google Scholar : PubMed/NCBI
27	Fu HY, Li C, Yang W, Gai XD, Jia T, Lei YM and Li Y: FOXP3 and TLR4 protein expression are correlated in non-small cell lung cancer: Implications for tumor progression and escape. Acta Histochem. 115:151–157. 2013. View Article : Google Scholar : PubMed/NCBI
28	Jia T, Fu H, Sun J, Zhang Y, Yang W and Li Y: Foxp3 expression in A549 cells is regulated by Toll-like receptor 4 through nuclear factor-κB. Mol Med Rep. 6:167–172. 2012.PubMed/NCBI
29	Κawai T and Akira S: The role of pattern recognition receptors in innate immunity: Update on Toll like receptors. Nat Immunol. 11:373–384. 2010. View Article : Google Scholar : PubMed/NCBI
30	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
31	Kim KH, Jo MS, Suh DS, Yoon MS, Shin DH, Lee JH and Choi KU: Expression and signification of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers. Word J Surg Oncol. 10:1932012. View Article : Google Scholar
32	Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH, Mayer L, Unkeless JC and Xiong H: Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 65:5009–5014. 2005. View Article : Google Scholar : PubMed/NCBI
33	Wang L, Zhao Y, Qian J, Sun L, Lu Y, Li H, Li Y, Yanq J, Cai Z and Yi Q: Toll-like receptor-4 signaling in mantle cell lymphoma: Effects on tumor growth and immune evasion. Cancer. 119:782–791. 2013. View Article : Google Scholar : PubMed/NCBI
34	Goto Y, Arigami T, Kitago M, Nquyen SL, Narita N, Ferrone S, Morton DL, Irie RF and Hoon DS: Activation of Toll-like receptors 2, 3 and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther. 7:3642–3653. 2008. View Article : Google Scholar : PubMed/NCBI
35	Hori S, Nomura T and Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057–1061. 2003. View Article : Google Scholar : PubMed/NCBI
36	Laouar Y, Welte T, Fu XY and Flavell RA: STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity. 19:903–912. 2003. View Article : Google Scholar : PubMed/NCBI
37	Welte T, Koch F, Schuler G, Lechner J, Doppler W and Heufler C: Granulocyte-macrophage colony-stimulating factor induces a unique set of STAT factors in murine dendritic cells. Eur J Immunol. 27:2737–2740. 1997. View Article : Google Scholar : PubMed/NCBI
38	Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P and Zhang Y: Histone demethylation by a family of Jmjc domain-containing protein. Nature. 439:811–816. 2006. View Article : Google Scholar : PubMed/NCBI
39	Okada Y, Scott G, Ray MK, Mishina Y and Zhang Y: Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis. Nature. 450:119–123. 2007. View Article : Google Scholar : PubMed/NCBI
40	Liu Z, Zhou S, Liao L, Chen X, Meisrrich M and Xu J: Jmjd1a demethylase-regulated histone modification is essential for cAMP-response element modulator-regulated gene expression and spermatogenesis. J Biol Chem. 285:2758–2770. 2010. View Article : Google Scholar : PubMed/NCBI
41	Parrish JK, Sechler M, Winn RA and Jedicka P: The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in ewing sarcoma. Oncogene. 34:257–262. 2015. View Article : Google Scholar : PubMed/NCBI
42	Uemura M, Yamamoto H, Takemasa I, Mimori K, Hemmi H, Mizushima T, Ikeda M, Sekimoto M, Matsuura N, Doki Y and Mori M: Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: In vivo identification from hypoxic tumor cells. Clin Cancer Res. 16:4636–4646. 2010. View Article : Google Scholar : PubMed/NCBI
43	Mahajan K, Lawrence HR, Lawrence NJ and Mahajan NP: ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1. J Biol Chem. 289:28179–28191. 2014. View Article : Google Scholar : PubMed/NCBI